ABG Innovation Capital Partners III GP Ltd Long-Term Concentrated

CIK: 0001845297 · Show all filings

Period: Q2 2022 (← Previous) (Next →)

Filing Date: Aug 15, 2022

Total Value ($000): $1,344 (100.0% shares, 0.0% debt)

Holdings (6)

CSTL CASTLE BIOSCIENCES INC 54.9%

Value ($000) $738 Shares 33,626 Est. Cost $23.24 Unrealized 0.0%

WHWK AADI BIOSCIENCES INC 24.5%

Value ($000) $329 Shares 26,666 Est. Cost $30.48 Unrealized -51.3%

— SYNLOGIC INC 17.6%

Value ($000) $237 Shares 205,906 Est. Cost $2.16 Unrealized —

— IDERA PHARMACEUTICALS INC 1.9%

Value ($000) $26 Shares 56,250 Est. Cost $3.66 Unrealized —

— NABRIVA THERAPEUTICS PLC 0.6%

Value ($000) $8 Shares 45,849 Est. Cost $2.42 Unrealized —

GNCAQ GENOCEA BIOSCIENCES INC 0.4%

Value ($000) $6 Shares 375,000 Est. Cost $2.28 Unrealized -87.7%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
CSTL	CASTLE BIOSCIENCES INC	33,626	$738	54.9%	$23.24	0.0%	COM	14843C105
WHWK	AADI BIOSCIENCES INC	26,666	$329	24.5%	$30.48	-51.3%	COM	00032Q104
—	SYNLOGIC INC	205,906	$237	17.6%	$2.16	—	COM	87166L100
—	IDERA PHARMACEUTICALS INC	56,250	$26	1.9%	$3.66	—	COM PAR	45168K405
—	NABRIVA THERAPEUTICS PLC	45,849	$8	0.6%	$2.42	—	SHS	G63637113
GNCAQ	GENOCEA BIOSCIENCES INC	375,000	$6	0.4%	$2.28	-87.7%	COM NEW	372427401